Statistics

Total Visits

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study57

Select a period of time:

Number of views in the range

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study13

Views

Views
July 20257
August 20250
September 20253
October 20251
November 20250
December 20252
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil7
United States2
Germany1
Ecuador1
United Kingdom1
Mexico1
 

Top cities views

Views
Ashburn1
Brasília1
Curitiba1
Frankfurt am Main1
Guarantã do Norte1
Guayaquil1
Limoeiro do Norte1
São Paulo1
Tijuana1
Torquay1